Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
25.86
+0.20 (0.78%)
Dec 20, 2024, 4:00 PM EST - Market closed
Immunovant Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 20, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
| Market Capitalization | 3,796 | 4,694 | 2,005 | 641 | 1,571 | 851 | |
| Market Cap Growth | -17.31% | 134.16% | 212.60% | -59.19% | 84.72% | - | |
| Enterprise Value | 3,323 | 4,004 | 1,574 | 117 | 1,153 | 730 | |
| Last Close Price | 25.86 | 32.31 | 15.51 | 5.51 | 16.04 | 15.56 | |
| PB Ratio | 8.44 | 7.60 | 5.53 | 1.37 | 4.01 | 9.04 | |
| P/TBV Ratio | 9.29 | 7.60 | 5.53 | 1.37 | 4.01 | 9.04 | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.03 | |
| Quick Ratio | 7.12 | 13.18 | 8.72 | 11.38 | 21.38 | 6.76 | |
| Current Ratio | 7.61 | 13.70 | 9.34 | 11.52 | 21.79 | 7.12 | |
| Return on Equity (ROE) | -92.17% | -52.91% | -50.69% | -36.39% | -44.25% | -130.93% | |
| Return on Assets (ROA) | -54.54% | -31.50% | -28.26% | -21.02% | -25.90% | -64.70% | |
| Return on Capital (ROIC) | -62.80% | -34.41% | -31.15% | -22.49% | -27.46% | -76.22% | |
| Earnings Yield | -8.51% | -5.52% | -10.52% | -24.44% | -6.84% | -7.80% | |
| FCF Yield | -7.17% | -4.57% | -9.40% | -16.58% | -5.32% | -6.28% | |
| Buyback Yield / Dilution | -12.00% | -12.21% | -12.21% | -24.98% | -103.14% | -94.85% | |
| Total Shareholder Return | -12.00% | -12.21% | -12.21% | -24.98% | -103.14% | -94.85% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.